KI-SS web header 4

Kirby at CROI 2024

Joanne Carson, Lucette Cysique & Nick Medland recap key Kirby presentations from the conference

Event date
Tuesday 2 April 2024
Event time
1:00pm - 2:00pm
Event address
In-person & online. Kirby Institute, Seminar Room Level 6, Wallace Wurth Building, Kensington Campus, UNSW Sydney

Hear from the Kirby Institute's presenters at this year's Conference on Retroviruses and Opportunistic Infections, CROI 2024. Our speakers will present key insights directly from the conference, offering a firsthand look at their research in infectious diseases.

Dr Joanne Carson will explore the elimination of HCV among people with HIV. The CEASE study assessed the impact of rapid scale up of direct acting antiviral therapy among people with HIV-HCV coinfection.

Associate Professor Lucette Cysique will present on the highlights from CROI 2024 NeuroHIV studies.

Dr Nick Medland will present findings from a study that uses five years of prescription and dispensing data to examine HIV acquisition in people who have received Australian government subsidised PrEP.

Joanne Carson

Dr Joanne Carson
Research Associate, Therapeutic and Vaccine Research Program/Viral Hepatitis Clinical Research Program, Kirby Institute

Joanne Carson is a cross-disciplinary infectious disease and data science researcher. Joanne recently completed her PhD in clinical epidemiology and data science. She is interested in applying novel statistical methodologies including machine learning and artificial intelligence, to analyse clinical and population-level health data with a specific focus on infectious diseases. 

Lucette Cysique

Associate Professor Lucette Cysique
Associate Professor, Viral Immunology Systems Program, Kirby Institute,  Associate Professor, UNSW Psychology, Asociate Professor, St. Vincent’s Hospital Centre for Applied Medical Research

Lucette Cysique is a neuropsychologist with longstanding research and clinical experience in the impact of infectious diseases (i.e., HCV, HIV,
SARS-CoV2) on the brain, cognition and mental health. She currently co-lead the APPRISE Long COVID initiative.

Nick Medland

Dr Nick Medland
Sexual Health and HIV physician, Researcher, Surveillance and Evaluation Research Program, Kirby Institute

Nick Medland is a sexual health and HIV physician, immediate past president of ASHM and chairs the Australian STI management guidelines. He has been at the Kirby Institute since 2018 and his area of research is the population control of HIV and sexually transmitted infection through clinical interventions, including HIV treatment as prevention and pre-exposure prophylaxis and STI testing and treatment. He has more than 25 years clinical experience, including in the community setting. For six years he worked in senior roles in US Government funded HIV programs in Vietnam


Opinions expressed by individuals at this event are solely of those of the individual/s and do not necessarily represent the views or opinions of the Kirby Institute or UNSW.